Skip to main content
SpringerLink
Log in

Ultrasound Assessment of Brachial Artery Reactivity

  • Chapter
  • First Online:
Asymptomatic Atherosclerosis

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 1276 Accesses

Abstract

Conventional cardiovascular risk factors do not always provide sufficiently accurate estimates of cardiovascular risk. Detection of arterial abnormalities that antedate clinical cardiovascular disease could potentially help refine cardiovascular risk assessment. Brachial artery reactivity testing (BART) is a noninvasive modality to detect endothelial dysfunction, an early feature of atherogenesis. An increase in brachial artery blood flow is brought about through transient forearm occlusion, and high-resolution ultrasonography is used to measure the resulting flow-mediated dilatation (FMD) of the brachial artery, a vascular response that is believed to result at least in part from the hyperemia-induced release of nitric oxide from the endothelium in the upstream conduit artery. FMD is impaired in asymptomatic subjects with cardiovascular risk factors as well as in subjects with known cardiovascular disease. Several studies have shown impaired FMD to be associated with increased incidence of adverse cardiovascular events in select high-risk populations. Recent studies have also shown FMD to be predictive of future cardiovascular events in asymptomatic individuals. Furthermore, because endothelial dysfunction is involved in the development of atherosclerosis and its sequelae, FMD could be used as an intermediate endpoint to monitor risk-reduction therapy. BART may also be used to assess forearm microcirculatory function that has been recently shown to provide insights into pathophysiology of cardiovascular disease and to correlate with cardiovascular risk factor burden. Thus, BART appears to be a promising adjunct in cardiovascular risk assessment. However, there is need to have more data about the incremental prognostic value of FMD in asymptomatic individuals and to establish its usefulness in treatment monitoring. There is also a need to establish consensus risk-defining cut-off values of FMD.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. American Heart Association HDaSSUD, TX: American Heart Association, 2006http://www.americanheart.org/presenter.jhtml?identifier=3000090 Accessed June 11, 2006. American Heart Association, Heart Disease and Stroke Statistics – 2006 Update. Dallas, TX: American Heart Association

  2. Zipes DP, Wellens HJ. Sudden cardiac death. Circulation. 1998;98:2334–2351.

    PubMed  CAS  Google Scholar 

  3. Greenland P, Abrams J, Aurigemma GP, et al. Prevention Conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation. 2000;101:E16–E22.

    PubMed  CAS  Google Scholar 

  4. Kullo IJ, Ballantyne CM. Conditional risk factors for atherosclerosis. Mayo Clin Proc. 2005;80:219–230.

    PubMed  Google Scholar 

  5. Naghavi M, Falk E, Hecht HS, et al. From vulnerable plaque to vulnerable patient--Part III: executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol. 2006;98:2H–15H.

    PubMed  Google Scholar 

  6. Fathi R, Marwick TH. Noninvasive tests of vascular function and structure: why and how to perform them. Am Heart J. 2001;141:694–703.

    PubMed  CAS  Google Scholar 

  7. Jacoby DS, Mohler IE, Rader DJ. Noninvasive atherosclerosis imaging for predicting cardiovascular events and assessing therapeutic interventions. Curr Atheroscler Rep. 2004;6:20–26.

    PubMed  Google Scholar 

  8. Patel SN, Rajaram V, Pandya S, et al. Emerging, noninvasive surrogate markers of atherosclerosis. Curr Atheroscler Rep. 2004;6:60–68.

    PubMed  Google Scholar 

  9. Landmesser U, Hornig B, Drexler H. Endothelial function: a critical determinant in atherosclerosis? Circulation. 2004;109:II27–II33.

    PubMed  Google Scholar 

  10. Schachinger V, Zeiher AM. Atherogenesis – recent insights into basic mechanisms and their clinical impact. Nephrol Dial Transplant. 2002;17:2055–2064.

    PubMed  Google Scholar 

  11. Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation. 2005;111:363–368.

    PubMed  Google Scholar 

  12. Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med. 1999;340:115–126.

    PubMed  CAS  Google Scholar 

  13. Anderson TJ. Assessment and treatment of endothelial dysfunction in humans. J Am Coll Cardiol. 1999;34:631–638.

    PubMed  CAS  Google Scholar 

  14. Joannides R, Haefeli WE, Linder L, et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation. 1995;91:1314–1319.

    PubMed  CAS  Google Scholar 

  15. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature. 1999;399:601–605.

    PubMed  CAS  Google Scholar 

  16. Anderson TJ, Uehata A, Gerhard MD, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol. 1995;26:1235–1241.

    PubMed  CAS  Google Scholar 

  17. Takase B, Hamabe A, Satomura K, et al. Close relationship between the vasodilator response to acetylcholine in the brachial and coronary artery in suspected coronary artery disease. Int J Cardiol. 2005;105:58–66.

    PubMed  Google Scholar 

  18. Matsuo S, Matsumoto T, Takashima H, et al. The relationship between flow-mediated brachial artery vasodilation and coronary vasomotor responses to bradykinin: comparison with those to acetylcholine. J Cardiovasc Pharmacol. 2004;44:164–170.

    PubMed  CAS  Google Scholar 

  19. Kao YH, Mohler ER, Arger PH, Sehgal CM. Brachial artery: measurement of flow-mediated dilatation with cross-sectional US – technical validation. Radiology. 2003;228:895–900.

    PubMed  Google Scholar 

  20. Chaudhry FA, Bangalore S, Upadya S, et al. Cross-sectional imaging identifies flow-mediated vasodilatation more accurately compared with longitudinal imaging. J Am Soc Echocardiogr. 2007;20:1380–1385.

    PubMed  Google Scholar 

  21. Peretz A, Leotta DF, Sullivan JH, et al. Flow mediated dilation of the brachial artery: an investigation of methods requiring further standardization. BMC Cardiovasc Disord. 2007;7:11.

    PubMed  Google Scholar 

  22. Agewall S, Doughty RN, Bagg W, Whalley GA, Braatvedt G, Sharpe N. Comparison of ultrasound assessment of flow-mediated dilatation in the radial and brachial artery with upper and forearm cuff positions. Clin Physiol. 2001;21:9–14.

    PubMed  CAS  Google Scholar 

  23. Black MA, Cable NT, Thijssen DH, Green DJ. Importance of measuring the time course of flow-mediated dilatation in humans. Hypertension. 2008;51:203–210.

    PubMed  CAS  Google Scholar 

  24. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow- mediated vasodilation of the brachial artery. A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39:257–265.

    PubMed  Google Scholar 

  25. Deanfield J, Donald A, Ferri C, et al. Endothelial function and dysfunction. Part I: methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens. 2005;23:7–17.

    PubMed  CAS  Google Scholar 

  26. Mannion TC, Vita JA, Keaney JF, Jr., Benjamin EJ, Hunter L, Polak JF. Non-invasive assessment of brachial artery endothelial vasomotor function: the effect of cuff position on level of discomfort and vasomotor responses. Vasc Med. 1998;3:263–267.

    PubMed  CAS  Google Scholar 

  27. Mullen MJ, Kharbanda RK, Cross J, et al. Heterogenous nature of flow-mediated dilatation in human conduit arteries in vivo: relevance to endothelial dysfunction in hypercholesterolemia. Circ Res. 2001;88:145–151.

    PubMed  CAS  Google Scholar 

  28. Hijmering ML, Stroes ES, Pasterkamp G, Sierevogel M, Banga JD, Rabelink TJ. Variability of flow mediated dilation: consequences for clinical application. Atherosclerosis. 2001;157:369–373.

    PubMed  CAS  Google Scholar 

  29. Jarvisalo MJ, Jartti L, Marniemi J, et al. Determinants of short-term variation in arterial flow-mediated dilatation in healthy young men. Clin Sci (Lond). 2006;110:475–482.

    Google Scholar 

  30. Thomas GN, Chook P, Qiao M, et al. Deleterious impact of “high normal” glucose levels and other metabolic syndrome components on arterial endothelial function and intima-media thickness in apparently healthy Chinese subjects: the CATHAY study. Arterioscler Thromb Vasc Biol. 2004;24:739–743.

    PubMed  CAS  Google Scholar 

  31. Giannattasio C, Zoppo A, Gentile G, et al. Acute effect of high-fat meal on endothelial function in moderately dyslipidemic subjects. Arterioscler Thromb Vasc Biol. 2005;25:406–410.

    PubMed  CAS  Google Scholar 

  32. Papamichael CM, Aznaouridis KA, Karatzis EN, et al. Effect of coffee on endothelial function in healthy subjects: the role of caffeine. Clin Sci (Lond). 2005;109:55–60.

    CAS  Google Scholar 

  33. Lekakis J, Papamichael C, Vemmos C, et al. Effect of acute cigarette smoking on endothelium-dependent brachial artery dilatation in healthy individuals. Am J Cardiol. 1997;79:529–531.

    PubMed  CAS  Google Scholar 

  34. Celermajer DS, Adams MR, et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med. 1996;334:150–154.

    PubMed  CAS  Google Scholar 

  35. Woo KS, Chook P, Leong HC, Huang XS, Celermajer DS. The impact of heavy passive smoking on arterial endothelial function in modernized Chinese. J Am Coll Cardiol. 2000;36:1228–1232.

    PubMed  CAS  Google Scholar 

  36. Abbott RA, Harkness MA, Davies PS. Correlation of habitual physical activity levels with flow-mediated dilation of the brachial artery in 5-10 year old children. Atherosclerosis. 2002;160:233–239.

    PubMed  CAS  Google Scholar 

  37. Clarkson P, Montgomery HE, Mullen MJ, et al. Exercise training enhances endothelial function in young men. J Am Coll Cardiol. 1999;33:1379–1385.

    PubMed  CAS  Google Scholar 

  38. Benjamin EJ, Larson MG, Keyes MJ, et al. Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study. Circulation. 2004;109:613–619.

    PubMed  Google Scholar 

  39. Kasikcioglu E, Oflaz H, Kasikcioglu HA, Kayserilioglu A, Umman S, Meric M. Endothelial flow-mediated dilatation and exercise capacity in highly trained endurance athletes. Tohoku J Exp Med. 2005;205:45–51.

    PubMed  Google Scholar 

  40. Otto ME, Svatikova A, Barretto RB, et al. Early morning attenuation of endothelial function in healthy humans. Circulation. 2004;109:2507–2510.

    PubMed  Google Scholar 

  41. Etsuda H, Takase B, Uehata A, et al. Morning attenuation of endothelium-dependent, flow-mediated dilation in healthy young men: possible connection to morning peak of cardiac events? Clin Cardiol. 1999;22:417–421.

    PubMed  CAS  Google Scholar 

  42. Ringqvist A, Caidahl K, Petersson AS, Wennmalm A. Diurnal variation of flow-mediated vasodilation in healthy premenopausal women. Am J Physiol Heart Circ Physiol. 2000;279:H2720–H2725.

    PubMed  CAS  Google Scholar 

  43. Harris KF, Matthews KA. Interactions between autonomic nervous system activity and endothelial function: a model for the development of cardiovascular disease. Psychosom Med. 2004;66:153–164.

    PubMed  Google Scholar 

  44. Hijmering ML, Stroes ES, Olijhoek J, Hutten BA, Blankestijn PJ, Rabelink TJ. Sympathetic activation markedly reduces endothelium-dependent, flow-mediated vasodilation. J Am Coll Cardiol. 2002;39:683–688.

    PubMed  Google Scholar 

  45. Harris CW, Edwards JL, Baruch A, et al. Effects of mental stress on brachial artery flow-mediated vasodilation in healthy normal individuals. Am Heart J. 2000;139:405–411.

    PubMed  CAS  Google Scholar 

  46. Lind L, Johansson K, Hall J. The effects of mental stress and the cold pressure test on flow-mediated vasodilation. Blood Press. 2002;11:22–27.

    PubMed  Google Scholar 

  47. Gottdiener JS, Kop WJ, Hausner E, McCeney MK, Herrington D, Krantz DS. Effects of mental stress on flow-mediated brachial arterial dilation and influence of behavioral factors and hypercholesterolemia in subjects without cardiovascular disease. Am J Cardiol. 2003;92:687–691.

    PubMed  Google Scholar 

  48. Hashimoto M, Akishita M, Eto M, et al. Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation. 1995;92:3431–3435.

    PubMed  CAS  Google Scholar 

  49. Kullo IJ, Malik AR, Santos S, Ehrsam JE, Turner ST. Association of cardiovascular risk factors with microvascular and conduit artery function in hypertensive subjects. Am J Hypertens. 2007;20:735–742.

    PubMed  Google Scholar 

  50. Herrington DM, Fan L, Drum M, et al. Brachial flow-mediated vasodilator responses in population-based research: methods, reproducibility and effects of age, gender and baseline diameter. J Cardiovasc Risk. 2001;8:319–328.

    PubMed  CAS  Google Scholar 

  51. Patel AR, Kuvin JT, Sliney KA, et al. Gender-based differences in brachial artery flow-mediated vasodilation as an indicator of significant coronary artery disease. Am J Cardiol. 2005;96:1223–1226.

    PubMed  Google Scholar 

  52. Celermajer DS, Sorensen KE, et al. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol. 1994;24:471–476.

    PubMed  CAS  Google Scholar 

  53. Bush DE, Jones CE, Bass KM, Walters GK, Bruza JM, Ouyang P. Estrogen replacement reverses endothelial dysfunction in postmenopausal women. Am J Med. 1998;104:552–558.

    PubMed  CAS  Google Scholar 

  54. Takase B, Akima T, Uehata A, Ohsuzu F, Kurita A. Effect of chronic stress and sleep deprivation on both flow-mediated dilation in the brachial artery and the intracellular magnesium level in humans. Clin Cardiol. 2004;27:223–227.

    PubMed  Google Scholar 

  55. Harris KF, Matthews KA, Sutton-Tyrrell K, Kuller LH. Associations between psychological traits and endothelial function in postmenopausal women. Psychosom Med. 2003;65:402–409.

    PubMed  Google Scholar 

  56. Rajagopalan S, Brook R, Rubenfire M, Pitt E, Young E, Pitt B. Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. Am J Cardiol. 2001;88:196–198, A197.

    PubMed  CAS  Google Scholar 

  57. Broadley AJ, Korszun A, Jones CJ, Frenneaux MP. Arterial endothelial function is impaired in treated depression. Heart (British Cardiac Society). 2002;88:521–523.

    CAS  Google Scholar 

  58. Tonetti MS, D’Aiuto F, Nibali L, et al. Treatment of periodontitis and endothelial function. N Engl J Med. 2007;356:911–920.

    PubMed  CAS  Google Scholar 

  59. Vlachopoulos C, Tsekoura D, Tsiamis E, Panagiotakos D, Stefanadis C. Effect of alcohol on endothelial function in healthy subjects. Vasc Med. 2003;8:263–265.

    PubMed  Google Scholar 

  60. Puddey IB, Zilkens RR, Croft KD, Beilin LJ. Alcohol and endothelial function: a brief review. Clin Exp Pharmacol Physiol. 2001;28:1020–1024.

    PubMed  CAS  Google Scholar 

  61. Maiorano G, Bartolomucci F, Contursi V, et al. Noninvasive detection of vascular dysfunction in alcoholic patients. Am J Hypertens. 1999;12:137–144.

    PubMed  CAS  Google Scholar 

  62. Zilkens RR, Rich L, Burke V, Beilin LJ, Watts GF, Puddey IB. Effects of alcohol intake on endothelial function in men: a randomized controlled trial. J Hypertens. 2003;21:97–103.

    PubMed  CAS  Google Scholar 

  63. Di Gennaro C, Biggi A, Barilli AL, et al. Endothelial dysfunction and cardiovascular risk profile in long-term withdrawing alcoholics. J Hypertens. 2007;25:367–373.

    PubMed  Google Scholar 

  64. Gokce N, Holbrook M, Hunter LM, et al. Acute effects of vasoactive drug treatment on brachial artery reactivity. J Am Coll Cardiol. 2002;40:761–765.

    PubMed  CAS  Google Scholar 

  65. Neunteufl T, Katzenschlager R, Hassan A, et al. Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. Atherosclerosis. 1997;129:111–118.

    PubMed  CAS  Google Scholar 

  66. Kaku B, Mizuno S, Ohsato K, et al. The correlation between coronary stenosis index and flow-mediated dilation of the brachial artery. Jpn Circ J. 1998;62:425–430.

    PubMed  CAS  Google Scholar 

  67. Schroeder S, Enderle MD, Ossen R, et al. Noninvasive determination of endothelium-mediated vasodilation as a screening test for coronary artery disease: pilot study to assess the predictive value in comparison with angina pectoris, exercise electrocardiography, and myocardial perfusion imaging. Am Heart J. 1999;138:731–739.

    PubMed  CAS  Google Scholar 

  68. Sondergaard E, Moller JE, Egstrup K. Relationship between vascular dysfunction in peripheral arteries and ischemic episodes during daily life in patients with ischemic heart disease and hypercholesterolemia. Am Heart J. 2002;144:108–114.

    PubMed  Google Scholar 

  69. Patti G, Pasceri V, Melfi R, et al. Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation. Circulation. 2005;111:70–75.

    PubMed  Google Scholar 

  70. Neunteufl T, Heher S, Katzenschlager R, et al. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol. 2000;86:207–210.

    PubMed  CAS  Google Scholar 

  71. Gokce N, Keaney JF, Jr., Hunter LM, Watkins MT, Menzoian JO, Vita JA. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study. Circulation. 2002;105:1567–1572.

    PubMed  Google Scholar 

  72. Gokce N, Keaney JF, Jr., Hunter LM, et al. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol. 2003;41:1769–1775.

    PubMed  Google Scholar 

  73. Chan SY, Mancini GB, Kuramoto L, Schulzer M, Frohlich J, Ignaszewski A. The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease. J Am Coll Cardiol. 2003;42:1037–1043.

    PubMed  CAS  Google Scholar 

  74. Meyer B, Mortl D, Strecker K, et al. Flow-mediated vasodilation predicts outcome in patients with chronic heart failure comparison with B-type natriuretic Peptide. J Am Coll Cardiol. 2005;46:1011–1018.

    PubMed  Google Scholar 

  75. Katz SD, Hryniewicz K, Hriljac I, et al. Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure. Circulation. 2005;111:310–314.

    PubMed  Google Scholar 

  76. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol. 1994;24:1468–1474.

    PubMed  CAS  Google Scholar 

  77. Witte DR, Westerink J, de Koning EJ, van der Graaf Y, Grobbee DE, Bots ML. Is the association between flow-mediated dilation and cardiovascular risk limited to low-risk populations? J Am Coll Cardiol. 2005;45:1987–1993.

    PubMed  Google Scholar 

  78. Shimbo D, Grahame-Clarke C, Miyake Y, et al. The association between endothelial dysfunction and cardiovascular outcomes in a population-based multi-ethnic cohort. Atherosclerosis. 2007;192:197–203.

    PubMed  CAS  Google Scholar 

  79. Yan RT, Anderson TJ, Charbonneau F, Title L, Verma S, Lonn E. Relationship between carotid artery intima-media thickness and brachial artery flow-mediated dilation in middle-aged healthy men. J Am Coll Cardiol. 2005;45:1980–1986.

    PubMed  Google Scholar 

  80. Yeboah J, Crouse JR, Hsu FC, Burke GL, Herrington DM. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation. 2007;115:2390–2397.

    PubMed  Google Scholar 

  81. Rossi R, Nuzzo A, Origliani G, Modena MG. Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women. J Am Coll Cardiol. 2008;51:997–1002.

    PubMed  Google Scholar 

  82. Celermajer DS. Endothelial dysfunction: does it matter? Is it reversible? J Am Coll Cardiol. 1997;30:325–333.

    PubMed  CAS  Google Scholar 

  83. Widlansky ME, Gokce N, Keaney JF, Jr., Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol. 2003;42:1149–1160.

    PubMed  CAS  Google Scholar 

  84. Dupuis J, Tardif JC, Rouleau JL, et al. Intensity of lipid lowering with statins and brachial artery vascular endothelium reactivity after acute coronary syndromes (from the BRAVER trial). Am J Cardiol. 2005;96:1207–1213.

    PubMed  CAS  Google Scholar 

  85. Dogra GK, Watts GF, Chan DC, Stanton K. Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria. Diabet Med. 2005;22:239–242.

    PubMed  CAS  Google Scholar 

  86. Jensen LO, Thayssen P, Pedersen KE, Haghfelt T. Short- and long-term influence of diet and simvastatin on brachial artery endothelial function. Int J Cardiol. 2006;107:101–106.

    PubMed  Google Scholar 

  87. Alber HF, Frick M, Sussenbacher A, et al. Effect of atorvastatin on peripheral endothelial function and systemic inflammatory markers in patients with stable coronary artery disease. Wiener Medizinische Wochenschrift. 2007;157:73–78.

    PubMed  Google Scholar 

  88. Ferreira WP, Bertolami MC, Santos SN, et al. One-month therapy with simvastatin restores endothelial function in hypercholesterolemic children and adolescents. Pediatr Cardiol. 2007;28:8–13.

    PubMed  Google Scholar 

  89. Agewall S, Hernberg A. Atorvastatin normalizes endothelial function in healthy smokers. Clin Sci (Lond). 2006;111:87–91.

    CAS  Google Scholar 

  90. Mancini GB, Henry GC, Macaya C, et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation. 1996;94:258–265

    PubMed  CAS  Google Scholar 

  91. Anderson TJ, Elstein E, Haber H, Charbonneau F. Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study). J Am Coll Cardiol. 2000;35:60–66.

    PubMed  CAS  Google Scholar 

  92. Spring S, Simon R, van der Loo B, et al. High-dose atorvastatin in peripheral arterial disease (PAD): effect on endothelial function, intima-media-thickness and local progression of PAD. An open randomized controlled pilot trial. Thromb Haemost. 2008;99:182–189.

    PubMed  CAS  Google Scholar 

  93. Asselbergs FW, van der Harst P, van Roon AM, et al. Long-term effects of pravastatin and fosinopril on peripheral endothelial function in albuminuric subjects. Atherosclerosis. 2008;196:349–355.

    PubMed  CAS  Google Scholar 

  94. Vogel RA, Corretti MC, Plotnick GD. Changes in flow-mediated brachial artery vasoactivity with lowering of desirable cholesterol levels in healthy middle-aged men. Am J Cardiol. 1996;77:37–40.

    PubMed  CAS  Google Scholar 

  95. Omori H, Nagashima H, Tsurumi Y, et al. Direct in vivo evidence of a vascular statin: a single dose of cerivastatin rapidly increases vascular endothelial responsiveness in healthy normocholesterolaemic subjects. Br J Clin Pharmacol. 2002;54:395–399.

    PubMed  CAS  Google Scholar 

  96. Mercuro G, Zoncu S, Saiu F, Sarais C, Rosano GM. Effect of atorvastatin on endothelium-dependent vasodilation in postmenopausal women with average serum cholesterol levels. Am J Cardiol. 2002;90:747–750.

    PubMed  CAS  Google Scholar 

  97. Koh KK, Bui MN, Hathaway L, et al. Mechanism by which quinapril improves vascular function in coronary artery disease. Am J Cardiol. 1999;83:327–331.

    PubMed  CAS  Google Scholar 

  98. Modena MG, Bonetti L, Coppi F, Bursi F, Rossi R. Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J Am Coll Cardiol. 2002;40:505–510.

    PubMed  Google Scholar 

  99. Hashimoto M, Miyamoto Y, Matsuda Y, Akita H. New methods to evaluate endothelial function: non-invasive method of evaluating endothelial function in humans. J Pharmacol Sci. 2003;93:405–408.

    PubMed  CAS  Google Scholar 

  100. Lieberman EH, Gerhard MD, Uehata A, et al. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med. 1994;121:936–941.

    PubMed  CAS  Google Scholar 

  101. Mitchell GF, Parise H, Vita JA, et al. Local shear stress and brachial artery flow-mediated dilation: the Framingham Heart Study. Hypertension. 2004;44:134–139.

    PubMed  CAS  Google Scholar 

  102. Dakak N, Husain S, Mulcahy D, et al. Contribution of nitric oxide to reactive hyperemia: impact of endothelial dysfunction. Hypertension. 1998;32:9–15.

    PubMed  CAS  Google Scholar 

  103. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation. 2001;104:2673–2678.

    PubMed  CAS  Google Scholar 

  104. Perticone F, Ceravolo R, Pujia A, et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation. 2001;104:191–196.

    PubMed  CAS  Google Scholar 

  105. Huang AL, Silver AE, Shvenke E, et al. Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery. Arterioscler Thromb Vasc Biol. 2007;27:2113–2119.

    PubMed  CAS  Google Scholar 

  106. Mehta JL. Endothelium, coronary vasodilation, and organic nitrates. Am Heart J. 1995;129:382–391.

    PubMed  CAS  Google Scholar 

  107. Adams MR, Robinson J, McCredie R, et al. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. J Am Coll Cardiol. 1998;32:123–127.

    PubMed  CAS  Google Scholar 

  108. Yugar-Toledo JC, Tanus-Santos JE, Sabha M, et al. Uncontrolled hypertension, uncompensated type II diabetes, and smoking have different patterns of vascular dysfunction. Chest. 2004;125:823–830.

    PubMed  Google Scholar 

  109. Zhang X, Zhao SP, Li XP, Gao M, Zhou QC. Endothelium-dependent and -independent functions are impaired in patients with coronary heart disease. Atherosclerosis. 2000;149:19–24.

    PubMed  CAS  Google Scholar 

  110. Raitakari OT, Seale JP, Celermajer DS. Impaired vascular responses to nitroglycerin in subjects with coronary atherosclerosis. Am J Cardiol. 2001;87:217–219, A218.

    PubMed  CAS  Google Scholar 

  111. Jensen-Urstad K, Johansson J. Gender difference in age-related changes in vascular function. J Intern Med. 2001;250:29–36.

    PubMed  CAS  Google Scholar 

  112. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 2000;101:1899–1906.

    PubMed  CAS  Google Scholar 

  113. Jensen-Urstad K, Johansson J, Jensen-Urstad M. Vascular function correlates with risk factors for cardiovascular disease in a healthy population of 35-year-old subjects. J Intern Med. 1997;241:507–513.

    PubMed  CAS  Google Scholar 

  114. Corretti MC, Plotnick GD, Vogel RA. Correlation of cold pressor and flow-mediated brachial artery diameter responses with the presence of coronary artery disease. Am J Cardiol. 1995;75:783–787.

    PubMed  CAS  Google Scholar 

  115. Kuvin JT, Patel AR, Sidhu M, et al. Relation between high-density lipoprotein cholesterol and peripheral vasomotor function. Am J Cardiol. 2003;92:275–279.

    PubMed  CAS  Google Scholar 

  116. Gaenzer H, Neumayr G, Marschang P, Sturm W, Kirchmair R, Patsch JR. Flow-mediated vasodilation of the femoral and brachial artery induced by exercise in healthy nonsmoking and smoking men. J Am Coll Cardiol. 2001;38:1313–1319.

    PubMed  CAS  Google Scholar 

  117. Shechter M, Sharir M, Labrador MJ, Forrester J, Merz CN. Improvement in endothelium-dependent brachial artery flow-mediated vasodilation with low-density lipoprotein cholesterol levels <100 mg/dl. Am J Cardiol. 2000;86:1256–1259.

    PubMed  CAS  Google Scholar 

  118. Kullo IJ, Malik AR, Bielak LF, Sheedy PF, Turner ST, Peyser PA. Brachial artery diameter and vasodilator response to nitroglycerin but not flow-mediated dilation are associated with presence and quantity of coronary artery calcium in asymptomatic adults. Clin Sci (Lond). 2007;112:175–182.

    CAS  Google Scholar 

  119. Holubkov R, Karas RH, Pepine CJ, et al. Large brachial artery diameter is associated with angiographic coronary artery disease in women. Am Heart J. 2002;143:802–807.

    PubMed  Google Scholar 

  120. Woodman RJ, Playford DA, Watts GF, et al. Improved analysis of brachial artery ultrasound using a novel edge-detection software system. J Appl Physiol. 2001;91:929–937.

    PubMed  CAS  Google Scholar 

  121. Preik M, Lauer T, Heiss C, Tabery S, Strauer BE, Kelm M. Automated ultrasonic measurement of human arteries for the determination of endothelial function. Ultraschall in der Medizin. 2000;21:195–198.

    PubMed  CAS  Google Scholar 

  122. Faulx MD, Wright AT, Hoit BD. Detection of endothelial dysfunction with brachial artery ultrasound scanning. Am Heart J. 2003;145:943–951.

    PubMed  Google Scholar 

  123. Raitakari OT, Celermajer DS. Testing for endothelial dysfunction. Ann Med. 2000;32:293–304.

    PubMed  CAS  Google Scholar 

  124. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007;115:1285–1295.

    PubMed  Google Scholar 

  125. Wiesmann F, Petersen SE, Leeson PM, et al. Global impairment of brachial, carotid, and aortic vascular function in young smokers: direct quantification by high-resolution magnetic resonance imaging. J Am Coll Cardiol. 2004;44:2056–2064.

    PubMed  Google Scholar 

  126. Silber HA, Ouyang P, Bluemke DA, Gupta SN, Foo TK, Lima JA. Why is flow-mediated dilation dependent on arterial size? Assessment of the shear stimulus using phase-contrast magnetic resonance imaging. Am J Physiol Heart Circ Physiol. 2005;288:H822–H828.

    PubMed  CAS  Google Scholar 

  127. Hayward CS, Kraidly M, Webb CM, Collins P. Assessment of endothelial function using peripheral waveform analysis: a clinical application. J Am Coll Cardiol. 2002;40:521–528.

    PubMed  CAS  Google Scholar 

  128. Brevetti G, Silvestro A, Schiano V, Chiariello M. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation. 2003;108:2093–2098.

    PubMed  Google Scholar 

  129. Fathi R, Haluska B, Isbel N, Short L, Marwick TH. The relative importance of vascular structure and function in predicting cardiovascular events. J Am Coll Cardiol. 2004;43:616–623.

    PubMed  Google Scholar 

  130. Frick M, Suessenbacher A, Alber HF, et al. Prognostic value of brachial artery endothelial function and wall thickness. J Am Coll Cardiol. 2005;46:1006–1010.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA

    A. Rauoof Malik

  2. Department of Cardiovascular Diesease, Gonda Vascular Center,Mayo Clinic, Rochester, MN, USA

    Iftikhar J. Kullo

Authors
  1. A. Rauoof Malik
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Iftikhar J. Kullo
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Endothelix, Inc., El Rio 8275, Houston, 77054, USA

    Morteza Naghavi

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Malik, A.R., Kullo, I.J. (2011). Ultrasound Assessment of Brachial Artery Reactivity. In: Naghavi, M. (eds) Asymptomatic Atherosclerosis. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-179-0_29

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-179-0_29

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60327-178-3

  • Online ISBN: 978-1-60327-179-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation